BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease. J Virol 2019;93:e01011-19. [PMID: 31462575 DOI: 10.1128/JVI.01011-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pavulraj S, Kamel M, Stephanowitz H, Liu F, Plendl J, Osterrieder N, Azab W. Equine Herpesvirus Type 1 Modulates Cytokine and Chemokine Profiles of Mononuclear Cells for Efficient Dissemination to Target Organs. Viruses 2020;12:E999. [PMID: 32911663 DOI: 10.3390/v12090999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hussey GS, Giessler KS. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy? Vet J 2022;:105827. [PMID: 35405348 DOI: 10.1016/j.tvjl.2022.105827] [Reference Citation Analysis]
3 Gehlen H, Rutenberg D, Simon C, Reinhold-Fritzen B, Drozdzewska K. [Management and hygiene measures during an outbreak of herpes, influenza, strangles or infections with multidrug resistant bacteria]. Tierarztl Prax Ausg G Grosstiere Nutztiere 2022;50:115-25. [PMID: 35523188 DOI: 10.1055/a-1809-2163] [Reference Citation Analysis]
4 Warda FF, Ahmed HES, Shafik NG, Mikhael CA, Abd-ElAziz HMG, Mohammed WA, Shosha EA. Application of equine herpesvirus-1 vaccine inactivated by both formaldehyde and binary ethylenimine in equine. Vet World 2021;14:1815-21. [PMID: 34475703 DOI: 10.14202/vetworld.2021.1815-1821] [Reference Citation Analysis]